Ali Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis PeerVoice Clinical Pharmacology Audio

Visit https://www.peervoice.com/JEG860 to view the entire programme with slides. After completing “Ali Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis”, participants will be able to: Describe the limitations of current targeted immunotherapies for patients with generalised myasthenia gravis (gMG); Identify emerging targeted therapies for gMG; and Explain how emerging targeted therapies for gMG differentiate from other therapies within the same class.